COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
36	表皮水疱症	1

36. 表皮水疱症

---

臨床試験数 : 163 /  薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04186650 (ClinicalTrials.gov)	January 10, 2020	25/11/2019	Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts	Phase I/II ex Vivo Gene Therapy Clinical Trial for RDEB Using Autologous Skin Equivalent Grafts Genetically Corrected With a COL7A1-encoding SIN Retroviral Vector	Epidermolysis Bullosa Dystrophica, Recessive	Biological: COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin	Institut National de la Santé Et de la Recherche Médicale, France	NULL	Active, not recruiting	18 Years	N/A	All	3	Phase 1/Phase 2	France